カテゴリー： Market Monitor Global, 世界, 医療/バイオ

夜尿症治療薬の世界市場見通し2023年-2029年

◆英語タイトル：Drugs for Enuresis Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8489 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月（※2025年版があります。お問い合わせください。） ◆ページ数：72 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Drugs for Enuresis Market 調査レポートは次の情報を含め、グローバルにおけるの夜尿症治療薬市場規模と予測を収録しています。・世界の夜尿症治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の夜尿症治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の夜尿症治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「抗コリン薬」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

夜尿症治療薬のグローバル主要企業は、Allergan、 Ferring Pharmaceuticals, Inc.、 Pfizer Inc.、 Janssen Pharmaceuticals, Inc.、 Urovant Sciences, Inc.、 Astellas Pharma US, Inc.、 Bayer Corp、 Mallinckrodt, Inc.、 Shanghai Xudong Haipu Pharmaceutical Co., Ltd、 Guangdong Xianqiang Pharmaceutical Co., Ltd、 Beijing Zizhu Pharmaceutical Co., Ltd、 Shanghai Pharmaceutical Groupなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、夜尿症治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の夜尿症治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の夜尿症治療薬市場：タイプ別市場シェア、2022年
・抗コリン薬、三環系抗うつ薬、デスモプレシン

世界の夜尿症治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の夜尿症治療薬市場：用途別市場シェア、2022年
・病院、専門医院、その他

世界の夜尿症治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の夜尿症治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における夜尿症治療薬のグローバル売上、2018年-2023年
・主要企業における夜尿症治療薬のグローバル売上シェア、2022年
・主要企業における夜尿症治療薬のグローバル販売量、2018年-2023年
・主要企業における夜尿症治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Allergan、 Ferring Pharmaceuticals, Inc.、 Pfizer Inc.、 Janssen Pharmaceuticals, Inc.、 Urovant Sciences, Inc.、 Astellas Pharma US, Inc.、 Bayer Corp、 Mallinckrodt, Inc.、 Shanghai Xudong Haipu Pharmaceutical Co., Ltd、 Guangdong Xianqiang Pharmaceutical Co., Ltd、 Beijing Zizhu Pharmaceutical Co., Ltd、 Shanghai Pharmaceutical Group

*************************************************************

・調査・分析レポートの概要
夜尿症治療薬市場の定義
市場セグメント
世界の夜尿症治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の夜尿症治療薬市場規模
世界の夜尿症治療薬市場規模：2022年 VS 2029年
世界の夜尿症治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの夜尿症治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の夜尿症治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：抗コリン薬、三環系抗うつ薬、デスモプレシン
夜尿症治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、専門医院、その他
夜尿症治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別夜尿症治療薬市場規模 2022年と2029年
地域別夜尿症治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Allergan、 Ferring Pharmaceuticals, Inc.、 Pfizer Inc.、 Janssen Pharmaceuticals, Inc.、 Urovant Sciences, Inc.、 Astellas Pharma US, Inc.、 Bayer Corp、 Mallinckrodt, Inc.、 Shanghai Xudong Haipu Pharmaceutical Co., Ltd、 Guangdong Xianqiang Pharmaceutical Co., Ltd、 Beijing Zizhu Pharmaceutical Co., Ltd、 Shanghai Pharmaceutical Group
...

The drugs used to treat enuresis are mainly stimulants of central nervous system or antidiuretic hormones
This report aims to provide a comprehensive presentation of the global market for Drugs for Enuresis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Enuresis. This report contains market size and forecasts of Drugs for Enuresis in global, including the following market information:
Global Drugs for Enuresis Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Drugs for Enuresis Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Drugs for Enuresis companies in 2022 (%)
The global Drugs for Enuresis market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Anticholinergic Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Drugs for Enuresis include Allergan, Ferring Pharmaceuticals, Inc., Pfizer Inc., Janssen Pharmaceuticals, Inc., Urovant Sciences, Inc., Astellas Pharma US, Inc., Bayer Corp, Mallinckrodt, Inc. and Shanghai Xudong Haipu Pharmaceutical Co., Ltd, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drugs for Enuresis manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drugs for Enuresis Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Drugs for Enuresis Market Segment Percentages, by Type, 2022 (%)
Anticholinergic Drugs
Tricyclic Antidepressants
Desmopressin
Global Drugs for Enuresis Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Drugs for Enuresis Market Segment Percentages, by Application, 2022 (%)
Hospital
Specialist Clinic
Othere
Global Drugs for Enuresis Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Drugs for Enuresis Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drugs for Enuresis revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Drugs for Enuresis revenues share in global market, 2022 (%)
Key companies Drugs for Enuresis sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Drugs for Enuresis sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan
Ferring Pharmaceuticals, Inc.
Pfizer Inc.
Janssen Pharmaceuticals, Inc.
Urovant Sciences, Inc.
Astellas Pharma US, Inc.
Bayer Corp
Mallinckrodt, Inc.
Shanghai Xudong Haipu Pharmaceutical Co., Ltd
Guangdong Xianqiang Pharmaceutical Co., Ltd
Beijing Zizhu Pharmaceutical Co., Ltd
Shanghai Pharmaceutical Group
Outline of Major Chapters:
Chapter 1: Introduces the definition of Drugs for Enuresis, market overview.
Chapter 2: Global Drugs for Enuresis market size in revenue and volume.
Chapter 3: Detailed analysis of Drugs for Enuresis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Drugs for Enuresis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Drugs for Enuresis capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Drugs for Enuresis Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drugs for Enuresis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drugs for Enuresis Overall Market Size
2.1 Global Drugs for Enuresis Market Size: 2022 VS 2029
2.2 Global Drugs for Enuresis Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Drugs for Enuresis Sales: 2018-2029
3 Company Landscape
3.1 Top Drugs for Enuresis Players in Global Market
3.2 Top Global Drugs for Enuresis Companies Ranked by Revenue
3.3 Global Drugs for Enuresis Revenue by Companies
3.4 Global Drugs for Enuresis Sales by Companies
3.5 Global Drugs for Enuresis Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Drugs for Enuresis Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Drugs for Enuresis Product Type
3.8 Tier 1, Tier 2 and Tier 3 Drugs for Enuresis Players in Global Market
3.8.1 List of Global Tier 1 Drugs for Enuresis Companies
3.8.2 List of Global Tier 2 and Tier 3 Drugs for Enuresis Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Drugs for Enuresis Market Size Markets, 2022 & 2029
4.1.2 Anticholinergic Drugs
4.1.3 Tricyclic Antidepressants
4.1.4 Desmopressin
4.2 By Type – Global Drugs for Enuresis Revenue & Forecasts
4.2.1 By Type – Global Drugs for Enuresis Revenue, 2018-2023
4.2.2 By Type – Global Drugs for Enuresis Revenue, 2024-2029
4.2.3 By Type – Global Drugs for Enuresis Revenue Market Share, 2018-2029
4.3 By Type – Global Drugs for Enuresis Sales & Forecasts
4.3.1 By Type – Global Drugs for Enuresis Sales, 2018-2023
4.3.2 By Type – Global Drugs for Enuresis Sales, 2024-2029
4.3.3 By Type – Global Drugs for Enuresis Sales Market Share, 2018-2029
4.4 By Type – Global Drugs for Enuresis Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Drugs for Enuresis Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Specialist Clinic
5.1.4 Othere
5.2 By Application – Global Drugs for Enuresis Revenue & Forecasts
5.2.1 By Application – Global Drugs for Enuresis Revenue, 2018-2023
5.2.2 By Application – Global Drugs for Enuresis Revenue, 2024-2029
5.2.3 By Application – Global Drugs for Enuresis Revenue Market Share, 2018-2029
5.3 By Application – Global Drugs for Enuresis Sales & Forecasts
5.3.1 By Application – Global Drugs for Enuresis Sales, 2018-2023
5.3.2 By Application – Global Drugs for Enuresis Sales, 2024-2029
5.3.3 By Application – Global Drugs for Enuresis Sales Market Share, 2018-2029
5.4 By Application – Global Drugs for Enuresis Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Drugs for Enuresis Market Size, 2022 & 2029
6.2 By Region – Global Drugs for Enuresis Revenue & Forecasts
6.2.1 By Region – Global Drugs for Enuresis Revenue, 2018-2023
6.2.2 By Region – Global Drugs for Enuresis Revenue, 2024-2029
6.2.3 By Region – Global Drugs for Enuresis Revenue Market Share, 2018-2029
6.3 By Region – Global Drugs for Enuresis Sales & Forecasts
6.3.1 By Region – Global Drugs for Enuresis Sales, 2018-2023
6.3.2 By Region – Global Drugs for Enuresis Sales, 2024-2029
6.3.3 By Region – Global Drugs for Enuresis Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Drugs for Enuresis Revenue, 2018-2029
6.4.2 By Country – North America Drugs for Enuresis Sales, 2018-2029
6.4.3 US Drugs for Enuresis Market Size, 2018-2029
6.4.4 Canada Drugs for Enuresis Market Size, 2018-2029
6.4.5 Mexico Drugs for Enuresis Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Drugs for Enuresis Revenue, 2018-2029
6.5.2 By Country – Europe Drugs for Enuresis Sales, 2018-2029
6.5.3 Germany Drugs for Enuresis Market Size, 2018-2029
6.5.4 France Drugs for Enuresis Market Size, 2018-2029
6.5.5 U.K. Drugs for Enuresis Market Size, 2018-2029
6.5.6 Italy Drugs for Enuresis Market Size, 2018-2029
6.5.7 Russia Drugs for Enuresis Market Size, 2018-2029
6.5.8 Nordic Countries Drugs for Enuresis Market Size, 2018-2029
6.5.9 Benelux Drugs for Enuresis Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Drugs for Enuresis Revenue, 2018-2029
6.6.2 By Region – Asia Drugs for Enuresis Sales, 2018-2029
6.6.3 China Drugs for Enuresis Market Size, 2018-2029
6.6.4 Japan Drugs for Enuresis Market Size, 2018-2029
6.6.5 South Korea Drugs for Enuresis Market Size, 2018-2029
6.6.6 Southeast Asia Drugs for Enuresis Market Size, 2018-2029
6.6.7 India Drugs for Enuresis Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Drugs for Enuresis Revenue, 2018-2029
6.7.2 By Country – South America Drugs for Enuresis Sales, 2018-2029
6.7.3 Brazil Drugs for Enuresis Market Size, 2018-2029
6.7.4 Argentina Drugs for Enuresis Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Drugs for Enuresis Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Drugs for Enuresis Sales, 2018-2029
6.8.3 Turkey Drugs for Enuresis Market Size, 2018-2029
6.8.4 Israel Drugs for Enuresis Market Size, 2018-2029
6.8.5 Saudi Arabia Drugs for Enuresis Market Size, 2018-2029
6.8.6 UAE Drugs for Enuresis Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Allergan
7.1.1 Allergan Company Summary
7.1.2 Allergan Business Overview
7.1.3 Allergan Drugs for Enuresis Major Product Offerings
7.1.4 Allergan Drugs for Enuresis Sales and Revenue in Global (2018-2023)
7.1.5 Allergan Key News & Latest Developments
7.2 Ferring Pharmaceuticals, Inc.
7.2.1 Ferring Pharmaceuticals, Inc. Company Summary
7.2.2 Ferring Pharmaceuticals, Inc. Business Overview
7.2.3 Ferring Pharmaceuticals, Inc. Drugs for Enuresis Major Product Offerings
7.2.4 Ferring Pharmaceuticals, Inc. Drugs for Enuresis Sales and Revenue in Global (2018-2023)
7.2.5 Ferring Pharmaceuticals, Inc. Key News & Latest Developments
7.3 Pfizer Inc.
7.3.1 Pfizer Inc. Company Summary
7.3.2 Pfizer Inc. Business Overview
7.3.3 Pfizer Inc. Drugs for Enuresis Major Product Offerings
7.3.4 Pfizer Inc. Drugs for Enuresis Sales and Revenue in Global (2018-2023)
7.3.5 Pfizer Inc. Key News & Latest Developments
7.4 Janssen Pharmaceuticals, Inc.
7.4.1 Janssen Pharmaceuticals, Inc. Company Summary
7.4.2 Janssen Pharmaceuticals, Inc. Business Overview
7.4.3 Janssen Pharmaceuticals, Inc. Drugs for Enuresis Major Product Offerings
7.4.4 Janssen Pharmaceuticals, Inc. Drugs for Enuresis Sales and Revenue in Global (2018-2023)
7.4.5 Janssen Pharmaceuticals, Inc. Key News & Latest Developments
7.5 Urovant Sciences, Inc.
7.5.1 Urovant Sciences, Inc. Company Summary
7.5.2 Urovant Sciences, Inc. Business Overview
7.5.3 Urovant Sciences, Inc. Drugs for Enuresis Major Product Offerings
7.5.4 Urovant Sciences, Inc. Drugs for Enuresis Sales and Revenue in Global (2018-2023)
7.5.5 Urovant Sciences, Inc. Key News & Latest Developments
7.6 Astellas Pharma US, Inc.
7.6.1 Astellas Pharma US, Inc. Company Summary
7.6.2 Astellas Pharma US, Inc. Business Overview
7.6.3 Astellas Pharma US, Inc. Drugs for Enuresis Major Product Offerings
7.6.4 Astellas Pharma US, Inc. Drugs for Enuresis Sales and Revenue in Global (2018-2023)
7.6.5 Astellas Pharma US, Inc. Key News & Latest Developments
7.7 Bayer Corp
7.7.1 Bayer Corp Company Summary
7.7.2 Bayer Corp Business Overview
7.7.3 Bayer Corp Drugs for Enuresis Major Product Offerings
7.7.4 Bayer Corp Drugs for Enuresis Sales and Revenue in Global (2018-2023)
7.7.5 Bayer Corp Key News & Latest Developments
7.8 Mallinckrodt, Inc.
7.8.1 Mallinckrodt, Inc. Company Summary
7.8.2 Mallinckrodt, Inc. Business Overview
7.8.3 Mallinckrodt, Inc. Drugs for Enuresis Major Product Offerings
7.8.4 Mallinckrodt, Inc. Drugs for Enuresis Sales and Revenue in Global (2018-2023)
7.8.5 Mallinckrodt, Inc. Key News & Latest Developments
7.9 Shanghai Xudong Haipu Pharmaceutical Co., Ltd
7.9.1 Shanghai Xudong Haipu Pharmaceutical Co., Ltd Company Summary
7.9.2 Shanghai Xudong Haipu Pharmaceutical Co., Ltd Business Overview
7.9.3 Shanghai Xudong Haipu Pharmaceutical Co., Ltd Drugs for Enuresis Major Product Offerings
7.9.4 Shanghai Xudong Haipu Pharmaceutical Co., Ltd Drugs for Enuresis Sales and Revenue in Global (2018-2023)
7.9.5 Shanghai Xudong Haipu Pharmaceutical Co., Ltd Key News & Latest Developments
7.10 Guangdong Xianqiang Pharmaceutical Co., Ltd
7.10.1 Guangdong Xianqiang Pharmaceutical Co., Ltd Company Summary
7.10.2 Guangdong Xianqiang Pharmaceutical Co., Ltd Business Overview
7.10.3 Guangdong Xianqiang Pharmaceutical Co., Ltd Drugs for Enuresis Major Product Offerings
7.10.4 Guangdong Xianqiang Pharmaceutical Co., Ltd Drugs for Enuresis Sales and Revenue in Global (2018-2023)
7.10.5 Guangdong Xianqiang Pharmaceutical Co., Ltd Key News & Latest Developments
7.11 Beijing Zizhu Pharmaceutical Co., Ltd
7.11.1 Beijing Zizhu Pharmaceutical Co., Ltd Company Summary
7.11.2 Beijing Zizhu Pharmaceutical Co., Ltd Drugs for Enuresis Business Overview
7.11.3 Beijing Zizhu Pharmaceutical Co., Ltd Drugs for Enuresis Major Product Offerings
7.11.4 Beijing Zizhu Pharmaceutical Co., Ltd Drugs for Enuresis Sales and Revenue in Global (2018-2023)
7.11.5 Beijing Zizhu Pharmaceutical Co., Ltd Key News & Latest Developments
7.12 Shanghai Pharmaceutical Group
7.12.1 Shanghai Pharmaceutical Group Company Summary
7.12.2 Shanghai Pharmaceutical Group Drugs for Enuresis Business Overview
7.12.3 Shanghai Pharmaceutical Group Drugs for Enuresis Major Product Offerings
7.12.4 Shanghai Pharmaceutical Group Drugs for Enuresis Sales and Revenue in Global (2018-2023)
7.12.5 Shanghai Pharmaceutical Group Key News & Latest Developments
8 Global Drugs for Enuresis Production Capacity, Analysis
8.1 Global Drugs for Enuresis Production Capacity, 2018-2029
8.2 Drugs for Enuresis Production Capacity of Key Manufacturers in Global Market
8.3 Global Drugs for Enuresis Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Drugs for Enuresis Supply Chain Analysis
10.1 Drugs for Enuresis Industry Value Chain
10.2 Drugs for Enuresis Upstream Market
10.3 Drugs for Enuresis Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Drugs for Enuresis Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Drugs for Enuresis in Global Market
Table 2. Top Drugs for Enuresis Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Drugs for Enuresis Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Drugs for Enuresis Revenue Share by Companies, 2018-2023
Table 5. Global Drugs for Enuresis Sales by Companies, (K Units), 2018-2023
Table 6. Global Drugs for Enuresis Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Drugs for Enuresis Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Drugs for Enuresis Product Type
Table 9. List of Global Tier 1 Drugs for Enuresis Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drugs for Enuresis Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Drugs for Enuresis Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Drugs for Enuresis Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Drugs for Enuresis Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Drugs for Enuresis Sales (K Units), 2018-2023
Table 15. By Type - Global Drugs for Enuresis Sales (K Units), 2024-2029
Table 16. By Application – Global Drugs for Enuresis Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Drugs for Enuresis Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Drugs for Enuresis Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Drugs for Enuresis Sales (K Units), 2018-2023
Table 20. By Application - Global Drugs for Enuresis Sales (K Units), 2024-2029
Table 21. By Region – Global Drugs for Enuresis Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Drugs for Enuresis Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Drugs for Enuresis Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Drugs for Enuresis Sales (K Units), 2018-2023
Table 25. By Region - Global Drugs for Enuresis Sales (K Units), 2024-2029
Table 26. By Country - North America Drugs for Enuresis Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Drugs for Enuresis Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Drugs for Enuresis Sales, (K Units), 2018-2023
Table 29. By Country - North America Drugs for Enuresis Sales, (K Units), 2024-2029
Table 30. By Country - Europe Drugs for Enuresis Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Drugs for Enuresis Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Drugs for Enuresis Sales, (K Units), 2018-2023
Table 33. By Country - Europe Drugs for Enuresis Sales, (K Units), 2024-2029
Table 34. By Region - Asia Drugs for Enuresis Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Drugs for Enuresis Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Drugs for Enuresis Sales, (K Units), 2018-2023
Table 37. By Region - Asia Drugs for Enuresis Sales, (K Units), 2024-2029
Table 38. By Country - South America Drugs for Enuresis Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Drugs for Enuresis Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Drugs for Enuresis Sales, (K Units), 2018-2023
Table 41. By Country - South America Drugs for Enuresis Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Drugs for Enuresis Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Drugs for Enuresis Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Drugs for Enuresis Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Drugs for Enuresis Sales, (K Units), 2024-2029
Table 46. Allergan Company Summary
Table 47. Allergan Drugs for Enuresis Product Offerings
Table 48. Allergan Drugs for Enuresis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Allergan Key News & Latest Developments
Table 50. Ferring Pharmaceuticals, Inc. Company Summary
Table 51. Ferring Pharmaceuticals, Inc. Drugs for Enuresis Product Offerings
Table 52. Ferring Pharmaceuticals, Inc. Drugs for Enuresis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Ferring Pharmaceuticals, Inc. Key News & Latest Developments
Table 54. Pfizer Inc. Company Summary
Table 55. Pfizer Inc. Drugs for Enuresis Product Offerings
Table 56. Pfizer Inc. Drugs for Enuresis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Pfizer Inc. Key News & Latest Developments
Table 58. Janssen Pharmaceuticals, Inc. Company Summary
Table 59. Janssen Pharmaceuticals, Inc. Drugs for Enuresis Product Offerings
Table 60. Janssen Pharmaceuticals, Inc. Drugs for Enuresis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Janssen Pharmaceuticals, Inc. Key News & Latest Developments
Table 62. Urovant Sciences, Inc. Company Summary
Table 63. Urovant Sciences, Inc. Drugs for Enuresis Product Offerings
Table 64. Urovant Sciences, Inc. Drugs for Enuresis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Urovant Sciences, Inc. Key News & Latest Developments
Table 66. Astellas Pharma US, Inc. Company Summary
Table 67. Astellas Pharma US, Inc. Drugs for Enuresis Product Offerings
Table 68. Astellas Pharma US, Inc. Drugs for Enuresis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Astellas Pharma US, Inc. Key News & Latest Developments
Table 70. Bayer Corp Company Summary
Table 71. Bayer Corp Drugs for Enuresis Product Offerings
Table 72. Bayer Corp Drugs for Enuresis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Bayer Corp Key News & Latest Developments
Table 74. Mallinckrodt, Inc. Company Summary
Table 75. Mallinckrodt, Inc. Drugs for Enuresis Product Offerings
Table 76. Mallinckrodt, Inc. Drugs for Enuresis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Mallinckrodt, Inc. Key News & Latest Developments
Table 78. Shanghai Xudong Haipu Pharmaceutical Co., Ltd Company Summary
Table 79. Shanghai Xudong Haipu Pharmaceutical Co., Ltd Drugs for Enuresis Product Offerings
Table 80. Shanghai Xudong Haipu Pharmaceutical Co., Ltd Drugs for Enuresis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Shanghai Xudong Haipu Pharmaceutical Co., Ltd Key News & Latest Developments
Table 82. Guangdong Xianqiang Pharmaceutical Co., Ltd Company Summary
Table 83. Guangdong Xianqiang Pharmaceutical Co., Ltd Drugs for Enuresis Product Offerings
Table 84. Guangdong Xianqiang Pharmaceutical Co., Ltd Drugs for Enuresis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Guangdong Xianqiang Pharmaceutical Co., Ltd Key News & Latest Developments
Table 86. Beijing Zizhu Pharmaceutical Co., Ltd Company Summary
Table 87. Beijing Zizhu Pharmaceutical Co., Ltd Drugs for Enuresis Product Offerings
Table 88. Beijing Zizhu Pharmaceutical Co., Ltd Drugs for Enuresis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Beijing Zizhu Pharmaceutical Co., Ltd Key News & Latest Developments
Table 90. Shanghai Pharmaceutical Group Company Summary
Table 91. Shanghai Pharmaceutical Group Drugs for Enuresis Product Offerings
Table 92. Shanghai Pharmaceutical Group Drugs for Enuresis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Shanghai Pharmaceutical Group Key News & Latest Developments
Table 94. Drugs for Enuresis Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 95. Global Drugs for Enuresis Capacity Market Share of Key Manufacturers, 2021-2023
Table 96. Global Drugs for Enuresis Production by Region, 2018-2023 (K Units)
Table 97. Global Drugs for Enuresis Production by Region, 2024-2029 (K Units)
Table 98. Drugs for Enuresis Market Opportunities & Trends in Global Market
Table 99. Drugs for Enuresis Market Drivers in Global Market
Table 100. Drugs for Enuresis Market Restraints in Global Market
Table 101. Drugs for Enuresis Raw Materials
Table 102. Drugs for Enuresis Raw Materials Suppliers in Global Market
Table 103. Typical Drugs for Enuresis Downstream
Table 104. Drugs for Enuresis Downstream Clients in Global Market
Table 105. Drugs for Enuresis Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Drugs for Enuresis Segment by Type in 2022
Figure 2. Drugs for Enuresis Segment by Application in 2022
Figure 3. Global Drugs for Enuresis Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Drugs for Enuresis Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Drugs for Enuresis Revenue, 2018-2029 (US$, Mn)
Figure 7. Drugs for Enuresis Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Drugs for Enuresis Revenue in 2022
Figure 9. By Type - Global Drugs for Enuresis Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Drugs for Enuresis Revenue Market Share, 2018-2029
Figure 11. By Type - Global Drugs for Enuresis Sales Market Share, 2018-2029
Figure 12. By Type - Global Drugs for Enuresis Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Drugs for Enuresis Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Drugs for Enuresis Revenue Market Share, 2018-2029
Figure 15. By Application - Global Drugs for Enuresis Sales Market Share, 2018-2029
Figure 16. By Application - Global Drugs for Enuresis Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Drugs for Enuresis Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Drugs for Enuresis Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Drugs for Enuresis Revenue Market Share, 2018-2029
Figure 20. By Region - Global Drugs for Enuresis Sales Market Share, 2018-2029
Figure 21. By Country - North America Drugs for Enuresis Revenue Market Share, 2018-2029
Figure 22. By Country - North America Drugs for Enuresis Sales Market Share, 2018-2029
Figure 23. US Drugs for Enuresis Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Drugs for Enuresis Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Drugs for Enuresis Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Drugs for Enuresis Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Drugs for Enuresis Sales Market Share, 2018-2029
Figure 28. Germany Drugs for Enuresis Revenue, (US$, Mn), 2018-2029
Figure 29. France Drugs for Enuresis Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Drugs for Enuresis Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Drugs for Enuresis Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Drugs for Enuresis Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Drugs for Enuresis Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Drugs for Enuresis Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Drugs for Enuresis Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Drugs for Enuresis Sales Market Share, 2018-2029
Figure 37. China Drugs for Enuresis Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Drugs for Enuresis Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Drugs for Enuresis Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Drugs for Enuresis Revenue, (US$, Mn), 2018-2029
Figure 41. India Drugs for Enuresis Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Drugs for Enuresis Revenue Market Share, 2018-2029
Figure 43. By Country - South America Drugs for Enuresis Sales Market Share, 2018-2029
Figure 44. Brazil Drugs for Enuresis Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Drugs for Enuresis Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Drugs for Enuresis Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Drugs for Enuresis Sales Market Share, 2018-2029
Figure 48. Turkey Drugs for Enuresis Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Drugs for Enuresis Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Drugs for Enuresis Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Drugs for Enuresis Revenue, (US$, Mn), 2018-2029
Figure 52. Global Drugs for Enuresis Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Drugs for Enuresis by Region, 2022 VS 2029
Figure 54. Drugs for Enuresis Industry Value Chain
Figure 55. Marketing Channels

※参考情報

夜尿症（ enuresis）は、主に子供に見られる病状で、就寝中に自発的に尿を排泄してしまう状態を指します。この病状は、個々の成長段階や精神的な要因も影響するため、治療にはさまざまなアプローチがあります。夜尿症はしばしば心理的な負担を伴い、子供の自尊心や社会的な関係に悪影響を及ぼすこともあります。そのため、適切な治療を行うことが非常に重要です。

夜尿症の治療薬にはいくつかの種類があり、それぞれ異なる作用機序や効果を持っています。これらの薬剤は、症状の軽減や予防を目的として使用されます。

まずは、夜尿症治療に用いられる代表的な薬剤として、デスモプレシン（Desmopressin）があります。デスモプレシンは合成バソプレッシンの類似物で、抗利尿作用を持ちます。主に、尿生成を抑制することで夜間の尿量を減らす効果があります。この薬剤は、主に原発性夜尿症の子供に使用され、1日1回の服用が一般的です。デスモプレシンは副作用が少なく、安全性が高いとされていますので、多くの医師が推奨しています。

次に用いられる薬剤としては、トフソプラム（Tolterodine）やオキシブチニン（Oxybutynin）といった抗コリン薬があります。これらの薬剤は、膀胱の過活動を抑える作用があり、排尿のコントロールを助けます。抗コリン薬は、主に保存療法の一環として、他の治療法と併用されることがあります。ただし、これらの薬剤には副作用が伴う可能性があるため、医師の指導のもとで使用することが重要です。

それに加えて、セロトニン再取り込み阻害薬（SSRI）も選択肢の一つとされています。フルオキセチン（Fluoxetine）やセルトラリン（Sertraline）といったSSRIは、特に心理的な背景があると考えられる場合に使用されることが多いです。これらの薬剤は、気分を改善し、ストレスや不安を軽減することが期待されます。夜尿症の治療においては、心のケアも重要であり、必要に応じて精神的なサポートが求められます。

夜尿症の治療における薬剤の使用は、単独で行うこともあれば、他の治療法と併用されることもあります。具体的には、行動療法や生活習慣の改善といったアプローチが考慮されます。例えば、夜間の水分摂取量をコントロールする、トイレに行く習慣をつけるといった方法です。また、アラーム療法も有効とされる手法の一つです。これは、子供が尿意を感じた時にアラームが鳴るようにして、覚醒を促し、トイレに行く習慣を身につけさせる方法です。

関連技術としては、ウェアラブルデバイスやアプリケーションも注目されています。これらは尿の排出状況をモニタリングし、データを可視化することで、子供自身や保護者が症状の改善状況を把握しやすくするためのものです。特に、アプリケーションでは、生活習慣の改善に向けたアドバイスやリマインダー機能が備わっていることが多く、治療を続ける動機づけになります。

さらに、夜尿症の治療には、医師との定期的なフォローアップやカウンセリングが重要です。夜尿症が長期化すると、子供の精神的健康にも悪影響を及ぼす可能性があります。そのため、医療機関で適切な支援を受けることが肝要です。

以上のように、夜尿症の治療薬にはさまざまな種類があり、それぞれの特徴と作用機序に基づいて使用されます。患者の個別の状況に応じて最適な治療法を選択することが重要であり、医療専門家の指導のもとで包括的なアプローチを行うことが求められます。子供の健康と幸せを守るためにも、早期の適切な治療を心がけることが必要です。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 夜尿症治療薬の世界市場見通し2023年-2029年(Drugs for Enuresis Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

夜尿症治療薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp